Target
Glucagon receptor
Ligand
BDBM50007223
Substrate
n/a
Meas. Tech.
ChEMBL_1338727 (CHEMBL3242198)
IC50
100±n/a nM
Citation
 DeMong, DDai, XHwa, JMiller, MLin, SIKang, LStamford, AGreenlee, WYu, WWong, MLavey, BKozlowski, JZhou, GYang, DYPatel, BSoriano, AZhai, YSondey, CZhang, HLachowicz, JGrotz, DCox, KMorrison, RAndreani, TCao, YLiang, MMeng, TMcNamara, PWong, JBradley, PFeng, KIBelani, JChen, PDai, PGauuan, JLin, PZhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article
Target
Name:
Glucagon receptor
Synonyms:
GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR)
Type:
Enzyme
Mol. Mass.:
54026.92
Organism:
Homo sapiens (Human)
Description:
P47871
Residue:
477
Sequence:
MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF
  
Inhibitor
Name:
BDBM50007223
Synonyms:
CHEMBL3238215
Type:
Small organic molecule
Emp. Form.:
C34H41Cl2N7O2
Mol. Mass.:
650.641
SMILES:
CC(C)(C)[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC1(C)CC1)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:4.3,15.17,wD:7.6,c:11,(1.56,-50.44,;2.75,-51.42,;1.3,-51.96,;2.49,-52.94,;4.19,-50.89,;4.45,-49.37,;5.9,-48.84,;7.08,-49.83,;6.82,-51.35,;5.37,-51.88,;7.5,-48.35,;9.04,-48.29,;9.57,-49.74,;11.05,-50.15,;8.36,-50.69,;8.42,-52.22,;7.09,-53.01,;7.11,-54.55,;5.79,-55.33,;4.44,-54.58,;6.55,-56.66,;5.02,-56.65,;9.74,-53.01,;9.72,-54.55,;11.04,-55.34,;12.39,-54.59,;12.41,-53.05,;11.09,-52.26,;13.72,-55.38,;13.69,-56.92,;15.05,-54.62,;16.38,-55.41,;17.72,-54.65,;19.12,-55.29,;20.16,-54.16,;19.41,-52.82,;17.9,-53.12,;9.82,-46.96,;9.06,-45.62,;9.83,-44.29,;9.07,-42.96,;11.37,-44.3,;12.14,-45.64,;13.68,-45.65,;11.36,-46.97,)|
Structure:
Search PDB for entries with ligand similarity: